<DOC>
	<DOCNO>NCT02604667</DOCNO>
	<brief_summary>The purpose study well understand cause stroke people cancer . Active cancer increase risk stroke . The investigator know exactly occur one possible reason people cancer may thicker blood people without cancer . Thick blood sometimes cause blood clot form heart , travel brain cause stroke . This study do help figure cause stroke occur people cancer . The investigator expect information study help doctor effectively prevent treat stroke individual cancer .</brief_summary>
	<brief_title>Mechanisms Ischemic Stroke Cancer Patients</brief_title>
	<detailed_description>This prospective cross-sectional study examine unique mechanism ischemic stroke cancer patient . Enrollment occur New York-Presbyterian Hospital ( NYPH ) /Weill Cornell Medical Center ( WCMC ) Memorial Sloan Kettering Cancer Center ( MSKCC ) . Measurements occur NYPH/WCMC MSKCC Neurovascular Ultrasound Laboratories , MSKCC Central Laboratory , Sharp Laboratory University California , Davis . Three group adult patient enrol . Group 1 consist consecutive patient active solid tumor cancer acute ischemic stroke . Group 2 patient acute ischemic stroke cancer . Patients Groups 1 2 enrol 96 hour +/- 12 hour stroke onset . Group 3 include patient active solid tumor cancer stroke . This group allow u confirm difference stroke patient without cancer simply incidental finding expect cancer patient regardless thrombotic status . Demographics , comorbidities , stroke severity ( Groups 1 2 ) record admission use structured form . Study patient undergo three facet test : 1 ) Transcranial Doppler ( TCD ) microemboli detection ; 2 ) hematological biomarker test ; 3 ) peripheral blood leukocyte RNA gene expression analysis .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Inclusion Criteria 18 year age older Active solid tumor cancer ( Groups 1 3 ) MRI confirm acute ischemic stroke ( Groups 1 2 ) Available blood draw 96 hour ( +/ 12 hour ) last know well time ( Groups 1 2 ) within 2 week enrollment ( Group 3 ) Available TCD within 2 week enrollment Exclusion Criteria Primary brain tumor hematological cancer Treatment intravenous intraarterial thrombolysis mechanical embolectomy Platelets &lt; 50,000/mm3 International normalize ratio ( INR ) &gt; 1.5 Partial thromboplastin time ( PTT ) &gt; 45 second Hemodialysis within 14 day Active pregnancy Infection within 14 day per Infectious Diseases Society America ( IDSA ) criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Mechanisms</keyword>
	<keyword>Transcranial Doppler</keyword>
</DOC>